MGI
CRL icon

Miller Global Investments’s Charles River Laboratories CRL Stock Holding History

Miller Global Investments’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$417K Sell
1,837
-212
-10% -$37.8K 0.35% 95
2026
Q1 		$353K Sell
2,049
-64
-3% -$11.9K 0.32% 90
2025
Q4 		$422K Buy
+2,113
New +$383K 0.38% 86

Other funds holding CRL

CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return

Miller Global Investments's CRL Position: Q2 2026 in Review

Miller Global Investments reduced its Charles River Laboratories (CRL) stake by 10% in Q2 2026, selling an estimated $37.8K and leaving 1,837 shares worth $417K. The position accounts for 0.35% of the portfolio, ranked #95.

Miller Global Investments first reported a position in CRL in Q4 2025 and has held it in 3 quarters since. The position peaked at $422K in Q4 2025. 214 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Miller Global Investments held 1,837 shares of Charles River Laboratories worth $417K as of Q2 2026.
  • Miller Global Investments sold 212 Charles River Laboratories shares in Q2 2026, an estimated $37.8K.
  • Charles River Laboratories made up 0.35% of Miller Global Investments's portfolio in Q2 2026, its #95 holding.
  • Miller Global Investments first reported a position in Charles River Laboratories in Q4 2025 and has held it in 3 quarters since.
  • Miller Global Investments's Charles River Laboratories position peaked at $422K in Q4 2025.
  • 214 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Miller Global Investments's 13F filing for Q2 2026, filed 1 Jul 2026.